kabutan

Sumitomo Pharma, Returning to Profitability This Year

Thu Jul 31, 2025 3:30 pm JST Earnings

4506 Sumitomo Pharma Co., Ltd. 【IFRS】

Earnings Report

Sumitomo Pharma Co., Ltd. <4506> [TSE Prime] announced its financial results (based on IFRS) after the market closed on July 31st (15:30). The consolidated net income for the first quarter of the fiscal year ending March 2026 (April to June) decreased 29.7% from the same period last year to 11.2 billion yen.

However, the previously undisclosed forecast for the first half (April to September) shows that consolidated net income/loss turn into a profit of 56.0 billion yen (compared to a loss of 32.2 billion yen in the same period last year) , reaches new record high for the first time in eight terms.

In the most recent three-month period, from April to June (1Q), the operating profit/loss margin drastically improved from -3.4% in the same period last year to 18.9%.

Kabutan News

Actual Results

Accumulated Results 1st Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Jun, 2023 75,686 -51,567 -31,052 -38,865 -97.8 ー Jul 31, 2023 IFRS
Apr - Jun, 2024 90,675 -3,105 17,203 15,937 40.1 ー Jul 31, 2024 IFRS
Apr - Jun, 2025 108,002 20,400 11,932 11,206 28.2 ー Jul 31, 2025 IFRS
YoY +19.1% － -30.6% -29.7% -29.7%

Guidance Update

First Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2025 Prev ー ー ー ー － 0 May 13, 2025 IFRS
Apr - Sep, 2025 New 207,000 69,000 ー 56,000 141.0 0 Jul 31, 2025 IFRS
Revision Rate － － － － －

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 180,749 -8,179 -32,406 -32,229 -81.1 0 Oct 30, 2024 IFRS
Apr - Sep, 2025 Guidance 207,000 69,000 ー 56,000 141.0 0 Jul 31, 2025 IFRS
YoY +14.5% － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 314,558 -354,859 -323,114 -314,969 -792.8 0 May 14, 2024 IFRS
Mar, 2025 398,832 28,804 17,611 23,634 59.5 0 May 13, 2025 IFRS
Mar, 2026 Guidance 355,000 54,000 ー 40,000 100.7 0 May 13, 2025 IFRS
YoY -11.0% +87.5% － +69.2% +69.2%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Apr - Jun, 2024 90,675 -3,105 17,203 15,937 40.1 -3.4 Jul 31, 2024 IFRS
Jul - Sep, 2024 90,074 -5,074 -49,609 -48,166 -121.2 -5.6 Oct 30, 2024 IFRS
Oct - Dec, 2024 112,434 21,405 56,432 53,448 134.5 19.0 Jan 31, 2025 IFRS
Jan - Mar, 2025 105,649 15,578 -6,415 2,415 6.1 14.7 May 13, 2025 IFRS
Apr - Jun, 2025 108,002 20,400 11,932 11,206 28.2 18.9 Jul 31, 2025 IFRS
YoY +19.1% － -30.6% -29.7% -29.7%

Related Articles